Literature DB >> 3491837

Fibrin induces release of von Willebrand factor from endothelial cells.

J A Ribes, C W Francis, D D Wagner.   

Abstract

Addition of fibrinogen to human umbilical vein endothelial cells in culture resulted in release of von Willebrand factor (vWf) from Weibel-Palade bodies that was temporally related to formation of fibrin in the medium. Whereas no release occurred before gelation, the formation of fibrin was associated with disappearance of Weibel-Palade bodies and development of extracellular patches of immunofluorescence typical of vWf release. Release also occurred within 10 min of exposure to preformed fibrin but did not occur after exposure to washed red cells, clot liquor, or structurally different fibrin prepared with reptilase. Metabolically labeled vWf was immunopurified from the medium after release by fibrin and shown to consist of highly processed protein lacking pro-vWf subunits. The contribution of residual thrombin to release stimulated by fibrin was minimized by preparing fibrin clots with nonstimulatory concentrations of thrombin and by inhibiting residual thrombin with hirudin or heating. We conclude that fibrin formed at sites of vessel injury may function as a physiologic secretagogue for endothelial cells causing rapid release of stored vWf.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3491837      PMCID: PMC424001          DOI: 10.1172/JCI112771

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  The effect of fibrin on cultured vascular endothelial cells.

Authors:  J L Kadish; C E Butterfield; J Folkman
Journal:  Tissue Cell       Date:  1979       Impact factor: 2.466

2.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

4.  Structural studies of the functional heterogeneity of von Willebrand protein polymers.

Authors:  S E Martin; V J Marder; C W Francis; G H Barlow
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

5.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

6.  Localization of factor-VIII-related antigen in human vascular subendothelium.

Authors:  J H Rand; I I Sussman; R E Gordon; S V Chu; V Solomon
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

7.  Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.

Authors:  A M Dosne; E Dupuy; E Bodevin
Journal:  Thromb Res       Date:  1978-03       Impact factor: 3.944

8.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Exposure of platelet fibrinogen receptors by ADP and epinephrine.

Authors:  J S Bennett; G Vilaire
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

10.  Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen.

Authors:  M B Zucker; M J Broekman; K L Kaplan
Journal:  J Lab Clin Med       Date:  1979-11
View more
  34 in total

1.  Old concepts and new developments in the study of platelet aggregation.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

3.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Lack of effect of thrombin on fibrin(ogen)-endothelial cell interaction.

Authors:  E Réganon; V Vila; V Martínez-Sales; J Aznar
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

5.  Inducible release of an endothelial cell-specific protein.

Authors:  C W Carson; G G Hunder; K L Kaplan; C M Johnson
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

6.  Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation.

Authors:  Heidi R Flori; Lorraine B Ware; Meredith Milet; Michael A Matthay
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

7.  Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

Authors:  X X Wu; R E Gordon; R W Glanville; H J Kuo; R R Uson; J H Rand
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

8.  Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.

Authors:  Adam Miszta; Leonie Pelkmans; Theo Lindhout; Ganeshram Krishnamoorthy; Philip G de Groot; Coenraad H Hemker; Johan W M Heemskerk; Hilde Kelchtermans; Bas de Laat
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

Review 9.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

10.  P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.

Authors:  J P Stone; D D Wagner
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.